ACOs have great potential in helping achieve a more value-based delivery system, said Risa Lavizzo-Mourey, MD, MBA, outgoing president and CEO of the Robert Wood Johnson Foundation. She also discussed the challenges that safety net ACOs face in delivering care with fewer resources.
ACOs have great potential in helping achieve a more value-based delivery system, said Risa Lavizzo-Mourey, MD, MBA, outgoing president and CEO of the Robert Wood Johnson Foundation. She also discussed the challenges that safety net ACOs face in delivering care with fewer resources.
Transcript (slightly modified)
How do you see ACOs and their impact on population health evolving in the future?
Accountable care organizations are a relatively new phenomenon, but already they’re showing how they can shift the way we think about healthcare delivery. They are focused on better coordination, reducing waste, much better accountability for what patients actually want from the healthcare system. And so in a culture of health where we’re keenly interested in making sure that we’re getting the highest value for our healthcare dollar, accountable care organizations are really one of the bright lights that may lead us to being able to actually do that, within our very constrained healthcare resources.
How do the impacts of safety net ACOs on community health differ from other ACOs?
ACOs that are focused on the safety net population really are faced with delivering care to very complex patients, often in settings that are resource-constrained. If they have more than 30% Medicaid reimbursement, they’re going to have fewer resources coming in, and often the community does not have as many community-oriented resources. So you put all that together and the safety net ACOs really are dealing with a very high level of complexity, and have to draw on all of the resources of the community in order to ensure the health of that population.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Targeting Progression: Amivantamab’s Role in NSCLC After Osimertinib
October 24th 2024Amivantamab's role in non–small cell lung cancer (NSCLC) has been a highlight of the lung cancer space this year, with the 2 most recent approvals based on data from the MARIPOSA and MARIPOSA-2 trials.
Read More
Cost Barriers Continue to Limit Access to Fertility Care
October 24th 2024Of the 10% of women contacted for this survey who said that they or their partner had ever sought fertility assistance, only 7% were able to get the necessary care; cost was cited as the top reason for not being able to access fertility services.
Read More
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More